Comparison of Genotypic and Phenotypic HIV Type 1 Tropism Assay: Results from the Screening Samples of Cenicriviroc Study 202, a Randomized Phase II Trial in Treatment-Naive Subjects

Cenicriviroc is a once-daily oral CCR5/CCR2 antagonist in development for treatment of HIV infection. CVC Study 202 (652-2-202; NCT01338883) excluded treatment-naive subjects demonstrated to harbor non-R5 (CXCR4-tropic or dual-mixed) tropic HIV-1 by either genotypic or phenotypic tropism testing. He...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kagan, Ron M., Johnson, Erik P., Siaw, Martin F., Van Baelen, Ben, Ogden, Richard, Platt, Jamie L., Pesano, Rick L., Lefebvre, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2014
Assuntos:
Preclinical Studies/Drug Development
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3911766/
https://ncbi.nlm.nih.gov/pubmed/23875707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2013.0123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados